317638 Dipeptidylpeptidase IV Inhibitor II

317638
  
Retrieving price...
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Empirical FormulaCAS #
      C₁₆H₂₁N₃O₄ · HCl1258008-19-3
      Description
      Overview

      This product has been discontinued.





      A novel acylating inhibitor for the proline-specific peptidases dipeptidylpeptidase II and dipeptidylpeptidase IV. Acts as a potent reversible inhibitor of human placenta dipeptidylpeptidase II (Ki = 3.8 µM) and porcine kidney dipeptidylpeptidase IV (Ki = 1 µM). Combines the efficacy of aminoacyl pyrrolidides and the potential transacylating capability of diacylhydroxylamines.
      Half-life in buffered solution (pH 7.6) = 24 h (30°C).
      Catalogue Number317638
      Brand Family Calbiochem®
      References
      ReferencesDemuth, H.-U., et al. 1993. FEBS Lett. 320, 23.
      Product Information
      CAS number1258008-19-3
      FormWhite solid
      Hill FormulaC₁₆H₂₁N₃O₄ · HCl
      Chemical formulaC₁₆H₂₁N₃O₄ · HCl
      Structure formula ImageStructure formula Image
      Applications
      Biological Information
      Primary Targetdipeptylpeptidase 2 human placenta
      Primary Target K<sub>i</sub>3.8 µM
      Secondary targetporcine kidney dipeptylpeptidase 4 (IC₅₀ = 1 µM)
      Purity>90% by HPLC
      Physicochemical Information
      Peptide SequenceH-Glu-(NHO-Bz)-Pyr, HCl
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +15°C to +30°C
      Protect from Light Protect from light
      Protect from Moisture Protect from moisture
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Dipeptidylpeptidase IV Inhibitor II Certificates of Analysis

      TitleLot Number
      317638

      References

      Reference overview
      Demuth, H.-U., et al. 1993. FEBS Lett. 320, 23.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision07-April-2011 RFH
      DescriptionA novel acylating inhibitor for the proline-specific peptidase dipeptidylpeptidase II and dipeptidylpeptidase IV. Acts as a potent reversible inhibitor of human placenta dipeptidylpeptidase II (Ki = 3.8 µM) and porcine kidney dipeptidylpeptidase IV (Ki = 1 µM). Combines the efficacy of aminoacyl pyrrolidides and potential transacylating capability of diacylhydroxylamines. Half-life in buffered solution (pH 7.6) = 24 h (30°C).
      FormWhite solid
      CAS number1258008-19-3
      Chemical formulaC₁₆H₂₁N₃O₄ · HCl
      Peptide SequenceH-Glu-(NHO-Bz)-Pyr, HCl
      Structure formulaStructure formula
      Purity>90% by HPLC
      SolubilityDMSO (5 mg/ml), Ethanol (5 mg/ml), and H₂O (1 mg/ml)
      Storage +15°C to +30°C
      Protect from moisture
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesDemuth, H.-U., et al. 1993. FEBS Lett. 320, 23.